H.RES.527: Relating to breast implants, the Food and Drug Administration, and public health.

About This Bill

  • This bill was introduced in the 104th Congress
  • This bill is primarily about education
  • Introduced Sept. 19, 1996
  • Latest Major Action Sept. 25, 1996

Bill Summary

Expresses the sense of the House of Representatives that the Food and Drug Administration should: (1) ensure that women with breast cancer and other women seeking breast reconstruction have enhanced access to silicone gel breast implants; (2) eliminate requirements that those women participate in clinical studies in order to obtain the implants; and (3) issue a definitive statement on the relationship (or lack thereof) between silicone gel...

(Source: Library of Congress)

Bill Actions

Date Description
Referred to the House Committee on Commerce.
Referred to the Subcommittee on Health and Environment.
Sept. 19, 1996

Introduced in the House by David M. McIntosh (R-Ind.)

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page